Drug therapies and the risk of malignancy in Crohn's disease: results from the TREAT™ Restaurantmanhaj's (Q43778384)

26 November 2017

title

Drug therapies and the risk of malignancy in Crohn's disease: results from the TREAT™ Registry (English)

1 reference

26 November 2017

1 reference

William Jeffery Sandborn

series ordinal

8

object named as

William J Sandborn

1 reference

26 November 2017

2

Brian G Feagan

1 reference

26 November 2017

1

Gary R Lichtenstein

1 reference

26 November 2017

4

Bruce A Salzberg

1 reference

26 November 2017

6

Wayne Langholff

1 reference

26 November 2017

Russell D Cohen

3

1 reference

26 November 2017

Robert H Diamond

series ordinal

5

1 reference

26 November 2017

Anil Londhe

series ordinal

7

1 reference

26 November 2017

language of work or name

English

0 references

publication date

7 January 2014

1 reference

The American Journal of Gastroenterology

26 November 2017

published in

1 reference

26 November 2017

volume

109

1 reference

26 November 2017

issue

2

1 reference

26 November 2017

page(s)

212-223

1 reference

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.441

Azathioprine and anti-TNF alpha therapies in Crohn's disease: a review of pharmacology, clinical efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.441

Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.441

Noncolorectal malignancies in inflammatory bowel disease: more than meets the eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.441

Concomitant use of immunomodulators with anti-TNF in Crohn's disease: yes or no?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.441

A Systematic Review of Factors That Contribute to Hepatosplenic T-Cell Lymphoma in Patients With Inflammatory Bowel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.441

Safety of anti-tumor necrosis factor therapy in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.441

Nonmelanoma skin cancer in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.441

Risk of nonmelanoma skin cancer with azathioprine use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.441

Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.441

Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.441

Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: meta-analysis of placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.441

Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.441

Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn's disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.441

Management of Crohn's disease in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.441

Risk of malignancies in patients with rheumatoid arthritis treated with biologic therapy: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.441

Review article: malignancy on thiopurine treatment with special reference to inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.441

Mutagenicity and potential carcinogenicity of thiopurine treatment in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.441

Use of thiopurines in the treatment of inflammatory bowel disease is associated with an increased risk of non-melanoma skin cancer in an at-risk population: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.441

Lymphoma risk in inflammatory bowel disease: is it the disease or its treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.441

Inflammatory bowel disease as a risk factor for colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.441

Molecular pathways underlying IBD-associated colorectal neoplasia: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.441

Crohn's colitis: the incidence of dysplasia and adenocarcinoma in surgical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.441

Meta-analysis: diagnostic medical radiation exposure in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.441

Factors associated with radiation exposure in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.441

Rheumatoid arthritis disease-modifying antirheumatic drug intervention and utilization study: safety and etanercept utilization analyses from the RADIUS 1 and RADIUS 2 registries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.441

21 January 2018

Identifiers

DOI

10.1038/AJG.2013.441

1 reference

release_deat4bdlcre33efkvz2z3gryum

26 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/deat4bdlcre33efkvz2z3gryum

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference